Inventor · disambiguated record
Andy Tsun
Also filed as: TSUN ANDY
9 granted patents·13 pending applications·13 citations·filing 2013–2025
80Inventor score
Files withBIOTHEUS INC12INNOVENT BIOLOGICS SUZHOU CO LTD7BIOTHEUS SUZHOU CO LTD1INST PASTEUR OF SHANGHAI CHINESE ACAD OF SCIENCES1INST PASTEUR SHANGHAI CAS1
Top patents by PatentIndex Score
22 records- 0186US11292836B2Anti-CD47 antibodies and uses thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2018·Granted Apr 5, 2022·3 cites·20 claims
- 0285US10316089B2PD-1 antibodiesINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2016·Granted Jun 11, 2019·7 cites·31 claims
- 0375US11732044B2Anti-LAG-3 antibody and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2018·Granted Aug 22, 2023·1 cites·21 claims
- 0475US11485795B2Anti-PCSK9 antibody and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2017·Granted Nov 1, 2022·1 cites·29 claims
- 0572US10913801B2PD-1 antibodiesINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2017·Granted Feb 9, 2021·1 cites·16 claims
- 0660US2025297034A1Anti-vegf-anti-pd-l1 bispecific antibody, pharmaceutical composition of same, and uses thereofBIOTHEUS INC·Filed 2025·Application pending·0 cites
- 0759US12325759B2Anti-VEGF-anti-PD-L1 bispecific antibody, pharmaceutical composition of same, and uses thereofBIOTHEUS INC·Filed 2021·Granted Jun 10, 2025·0 cites·34 claims
- 0856US2025122296A1Bispecific antibody and use thereofBIOTHEUS INC·Filed 2022·Application pending·0 cites
- 0954US12409233B2Anti-PD-L1 single-domain antibody and derivatives and use thereofBIOTHEUS INC·Filed 2020·Granted Sep 9, 2025·0 cites·10 claims
- 1053US2025230255A1Anti-cd39 nanobody and uses thereofBIOTHEUS INC·Filed 2023·Application pending·0 cites
- 1153US2025223353A1Anti-pvrig antibody, pharmaceutical composition thereof and use thereofBIOTHEUS INC·Filed 2023·Application pending·0 cites
- 1253US2025223354A1Anti-tigit-anti-pvrig bispecific antibody, pharmaceutical composition thereof and use thereofBIOTHEUS INC·Filed 2023·Application pending·0 cites
- 1352US2025297009A1Anti-pd-1 monoclonal antibody, derivative thereof and use thereofBIOTHEUS INC·Filed 2023·Application pending·0 cites
- 1449US2023348627A1Anti-4-1bb-anti-pd-l1 bispecific antibody, and pharmaceutical composition and use thereofBIOTHEUS INC·Filed 2021·Application pending·0 cites
- 1549US2015073043A1Use of phosphorylation pathway-related factor in regulating function of regulatory t cellINST PASTEUR SHANGHAI CAS·Filed 2013·Application pending·0 cites
- 1649US2017189496A1Use of phosphorylation pathway-related factor in regulating function of regulatory t cellINST PASTEUR OF SHANGHAI CHINESE ACAD OF SCIENCES·Filed 2017·Application pending·0 cites
- 1748US2023357422A1Single-domain antibody targeting 4-1bb, fusion protein thereof, pharmaceutical composition and use thereofBIOTHEUS INC·Filed 2021·Application pending·0 cites
- 1848US2025345451A1Anti-pd-l1 single-domain antibody and derivatives and use thereofBIOTHEUS INC·Filed 2025·Application pending·0 cites
- 1947US11498972B2Anti-OX40 antibody and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2018·Granted Nov 15, 2022·0 cites·24 claims
- 2045US2023167200A1Platform for constructing multispecific antibodyBIOTHEUS INC·Filed 2021·Application pending·0 cites
- 2144US2022331416A1Combined expression of a chimeric cd3 fusion protein and an anti-cd3-based bispecific t cell activating elementBIOTHEUS SUZHOU CO LTD·Filed 2020·Application pending·0 cites
- 2242US10597454B2PD-1 antibodiesINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2016·Granted Mar 24, 2020·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Andy Tsun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →